Copyright Reports & Markets. All rights reserved.

Global Nanoparticle Drug Delivery Systems Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Nanoparticle Drug Delivery Systems by Type
    • 1.3.1 Overview: Global Nanoparticle Drug Delivery Systems Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Nanoparticle Drug Delivery Systems Consumption Value Market Share by Type in 2023
    • 1.3.3 Liposomes Drugs
    • 1.3.4 Lipid Nanoparticle Drugs
  • 1.4 Global Nanoparticle Drug Delivery Systems Market by Application
    • 1.4.1 Overview: Global Nanoparticle Drug Delivery Systems Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global Nanoparticle Drug Delivery Systems Market Size & Forecast
  • 1.6 Global Nanoparticle Drug Delivery Systems Market Size and Forecast by Region
    • 1.6.1 Global Nanoparticle Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Nanoparticle Drug Delivery Systems Market Size by Region, (2019-2030)
    • 1.6.3 North America Nanoparticle Drug Delivery Systems Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Nanoparticle Drug Delivery Systems Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size and Prospect (2019-2030)
    • 1.6.6 South America Nanoparticle Drug Delivery Systems Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Johnson & Johnson
    • 2.1.1 Johnson & Johnson Details
    • 2.1.2 Johnson & Johnson Major Business
    • 2.1.3 Johnson & Johnson Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.1.4 Johnson & Johnson Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.2 Sun Pharmaceutical
    • 2.2.1 Sun Pharmaceutical Details
    • 2.2.2 Sun Pharmaceutical Major Business
    • 2.2.3 Sun Pharmaceutical Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.2.4 Sun Pharmaceutical Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Sun Pharmaceutical Recent Developments and Future Plans
  • 2.3 CSPC
    • 2.3.1 CSPC Details
    • 2.3.2 CSPC Major Business
    • 2.3.3 CSPC Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.3.4 CSPC Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CSPC Recent Developments and Future Plans
  • 2.4 Kinyond
    • 2.4.1 Kinyond Details
    • 2.4.2 Kinyond Major Business
    • 2.4.3 Kinyond Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.4.4 Kinyond Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Kinyond Recent Developments and Future Plans
  • 2.5 Teva
    • 2.5.1 Teva Details
    • 2.5.2 Teva Major Business
    • 2.5.3 Teva Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.5.4 Teva Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Teva Recent Developments and Future Plans
  • 2.6 Fudan-Zhangjiang
    • 2.6.1 Fudan-Zhangjiang Details
    • 2.6.2 Fudan-Zhangjiang Major Business
    • 2.6.3 Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.6.4 Fudan-Zhangjiang Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Fudan-Zhangjiang Recent Developments and Future Plans
  • 2.7 Zydus Cadila
    • 2.7.1 Zydus Cadila Details
    • 2.7.2 Zydus Cadila Major Business
    • 2.7.3 Zydus Cadila Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.7.4 Zydus Cadila Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Zydus Cadila Recent Developments and Future Plans
  • 2.8 TTY Biopharma
    • 2.8.1 TTY Biopharma Details
    • 2.8.2 TTY Biopharma Major Business
    • 2.8.3 TTY Biopharma Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.8.4 TTY Biopharma Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 TTY Biopharma Recent Developments and Future Plans
  • 2.9 Pacira
    • 2.9.1 Pacira Details
    • 2.9.2 Pacira Major Business
    • 2.9.3 Pacira Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.9.4 Pacira Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Pacira Recent Developments and Future Plans
  • 2.10 Luye Pharma
    • 2.10.1 Luye Pharma Details
    • 2.10.2 Luye Pharma Major Business
    • 2.10.3 Luye Pharma Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.10.4 Luye Pharma Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Luye Pharma Recent Developments and Future Plans
  • 2.11 Leadiant Biosciences
    • 2.11.1 Leadiant Biosciences Details
    • 2.11.2 Leadiant Biosciences Major Business
    • 2.11.3 Leadiant Biosciences Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.11.4 Leadiant Biosciences Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Leadiant Biosciences Recent Developments and Future Plans
  • 2.12 Ipsen
    • 2.12.1 Ipsen Details
    • 2.12.2 Ipsen Major Business
    • 2.12.3 Ipsen Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.12.4 Ipsen Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Ipsen Recent Developments and Future Plans
  • 2.13 Sayre Therapeutics
    • 2.13.1 Sayre Therapeutics Details
    • 2.13.2 Sayre Therapeutics Major Business
    • 2.13.3 Sayre Therapeutics Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.13.4 Sayre Therapeutics Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Sayre Therapeutics Recent Developments and Future Plans
  • 2.14 Jazz
    • 2.14.1 Jazz Details
    • 2.14.2 Jazz Major Business
    • 2.14.3 Jazz Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.14.4 Jazz Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Jazz Recent Developments and Future Plans
  • 2.15 Alnylam
    • 2.15.1 Alnylam Details
    • 2.15.2 Alnylam Major Business
    • 2.15.3 Alnylam Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.15.4 Alnylam Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Alnylam Recent Developments and Future Plans
  • 2.16 Bausch Health
    • 2.16.1 Bausch Health Details
    • 2.16.2 Bausch Health Major Business
    • 2.16.3 Bausch Health Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.16.4 Bausch Health Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Bausch Health Recent Developments and Future Plans
  • 2.17 Acrotech Biopharma
    • 2.17.1 Acrotech Biopharma Details
    • 2.17.2 Acrotech Biopharma Major Business
    • 2.17.3 Acrotech Biopharma Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.17.4 Acrotech Biopharma Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Acrotech Biopharma Recent Developments and Future Plans
  • 2.18 Takeda
    • 2.18.1 Takeda Details
    • 2.18.2 Takeda Major Business
    • 2.18.3 Takeda Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.18.4 Takeda Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Takeda Recent Developments and Future Plans
  • 2.19 Chiesi Farmaceutici
    • 2.19.1 Chiesi Farmaceutici Details
    • 2.19.2 Chiesi Farmaceutici Major Business
    • 2.19.3 Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.19.4 Chiesi Farmaceutici Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Chiesi Farmaceutici Recent Developments and Future Plans
  • 2.20 Gilead Sciences
    • 2.20.1 Gilead Sciences Details
    • 2.20.2 Gilead Sciences Major Business
    • 2.20.3 Gilead Sciences Nanoparticle Drug Delivery Systems Product and Solutions
    • 2.20.4 Gilead Sciences Nanoparticle Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
    • 2.20.5 Gilead Sciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Nanoparticle Drug Delivery Systems Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Nanoparticle Drug Delivery Systems by Company Revenue
    • 3.2.2 Top 3 Nanoparticle Drug Delivery Systems Players Market Share in 2023
    • 3.2.3 Top 6 Nanoparticle Drug Delivery Systems Players Market Share in 2023
  • 3.3 Nanoparticle Drug Delivery Systems Market: Overall Company Footprint Analysis
    • 3.3.1 Nanoparticle Drug Delivery Systems Market: Region Footprint
    • 3.3.2 Nanoparticle Drug Delivery Systems Market: Company Product Type Footprint
    • 3.3.3 Nanoparticle Drug Delivery Systems Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Nanoparticle Drug Delivery Systems Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Nanoparticle Drug Delivery Systems Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Nanoparticle Drug Delivery Systems Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Nanoparticle Drug Delivery Systems Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Nanoparticle Drug Delivery Systems Consumption Value by Type (2019-2030)
  • 6.2 North America Nanoparticle Drug Delivery Systems Market Size by Application (2019-2030)
  • 6.3 North America Nanoparticle Drug Delivery Systems Market Size by Country
    • 6.3.1 North America Nanoparticle Drug Delivery Systems Consumption Value by Country (2019-2030)
    • 6.3.2 United States Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Nanoparticle Drug Delivery Systems Consumption Value by Type (2019-2030)
  • 7.2 Europe Nanoparticle Drug Delivery Systems Consumption Value by Application (2019-2030)
  • 7.3 Europe Nanoparticle Drug Delivery Systems Market Size by Country
    • 7.3.1 Europe Nanoparticle Drug Delivery Systems Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 7.3.3 France Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Nanoparticle Drug Delivery Systems Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Nanoparticle Drug Delivery Systems Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Nanoparticle Drug Delivery Systems Market Size by Region
    • 8.3.1 Asia-Pacific Nanoparticle Drug Delivery Systems Consumption Value by Region (2019-2030)
    • 8.3.2 China Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 8.3.5 India Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Nanoparticle Drug Delivery Systems Consumption Value by Type (2019-2030)
  • 9.2 South America Nanoparticle Drug Delivery Systems Consumption Value by Application (2019-2030)
  • 9.3 South America Nanoparticle Drug Delivery Systems Market Size by Country
    • 9.3.1 South America Nanoparticle Drug Delivery Systems Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Nanoparticle Drug Delivery Systems Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Nanoparticle Drug Delivery Systems Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Nanoparticle Drug Delivery Systems Market Size by Country
    • 10.3.1 Middle East & Africa Nanoparticle Drug Delivery Systems Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Nanoparticle Drug Delivery Systems Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Nanoparticle Drug Delivery Systems Market Drivers
  • 11.2 Nanoparticle Drug Delivery Systems Market Restraints
  • 11.3 Nanoparticle Drug Delivery Systems Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Nanoparticle Drug Delivery Systems Industry Chain
  • 12.2 Nanoparticle Drug Delivery Systems Upstream Analysis
  • 12.3 Nanoparticle Drug Delivery Systems Midstream Analysis
  • 12.4 Nanoparticle Drug Delivery Systems Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
    In this report, we only study liposomal/lipid nanoparticle drug delivery system.

    LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
    In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
    According to our (Global Info Research) latest study, the global Nanoparticle Drug Delivery Systems market size was valued at US$ 5164 million in 2023 and is forecast to a readjusted size of USD 9845 million by 2030 with a CAGR of 9.8% during review period.
    Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.
    Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.
    In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
    This report is a detailed and comprehensive analysis for global Nanoparticle Drug Delivery Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Nanoparticle Drug Delivery Systems market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Nanoparticle Drug Delivery Systems market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Nanoparticle Drug Delivery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Nanoparticle Drug Delivery Systems market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nanoparticle Drug Delivery Systems
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nanoparticle Drug Delivery Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Sun Pharmaceutical, CSPC, Kinyond, Teva, Fudan-Zhangjiang, Zydus Cadila, TTY Biopharma, Pacira, Luye Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Nanoparticle Drug Delivery Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Nanoparticle Drug Delivery Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Liposomes Drugs
    Lipid Nanoparticle Drugs
    Market segment by Application
    Hospital
    Retail Pharmacy
    Other
    Market segment by players, this report covers
    Johnson & Johnson
    Sun Pharmaceutical
    CSPC
    Kinyond
    Teva
    Fudan-Zhangjiang
    Zydus Cadila
    TTY Biopharma
    Pacira
    Luye Pharma
    Leadiant Biosciences
    Ipsen
    Sayre Therapeutics
    Jazz
    Alnylam
    Bausch Health
    Acrotech Biopharma
    Takeda
    Chiesi Farmaceutici
    Gilead Sciences
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Nanoparticle Drug Delivery Systems product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Nanoparticle Drug Delivery Systems, with revenue, gross margin, and global market share of Nanoparticle Drug Delivery Systems from 2019 to 2024.
    Chapter 3, the Nanoparticle Drug Delivery Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nanoparticle Drug Delivery Systems market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Nanoparticle Drug Delivery Systems.
    Chapter 13, to describe Nanoparticle Drug Delivery Systems research findings and conclusion.

    Buy now